BTK Archives - AdvocateHealthyu

Loxo Oncology Announces Initiation of Phase 1/2 Clinical Trial for Highly Selective, Non-Covalent BTK Inhibitor, LOXO-305

STAMFORD, Conn., Dec. 21, 2018 (GLOBE NEWSWIRE) — Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company…

Everybody desires great skin. But flawless and blemish-free skin is worth a lot. Everyone wants…

The risk of long-term health problems, hospitalization and death after a COVID-19 infection diminishes among…

DECATUR, Ill. — The question came out of the blue, or so it seemed to…

FDA Approves Suflave (polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride)…

FDA Approves Abilify Asimtufii (aripiprazole) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of…

At a health-screening event in Sarasota, Florida, people gathered in a parking lot and waited…

Reviewed The Winter CIS was launched jointly by the UK Health Security Agency (UKHSA) and…

Signs of injury to the brain’s white matter called white matter hyperintensities, as seen on…

A French appeals court on Wednesday ordered pharmaceutical firm Servier to pay more than $460…